CAH
Cardinal Health, Inc.
Is CAH Halal?
Leading global healthcare-services and medical-products distribution company — permissible medical-distribution business with manageable financial-screen profile.
What You Should Know
Cardinal Health, Inc. is one of the largest publicly-traded global healthcare-services and medical-products distribution companies in the world, organized into two reporting segments: Pharmaceutical and Specialty Solutions (the largest segment — distribution of branded and generic pharmaceutical products, specialty pharmaceuticals, over-the-counter healthcare products, consumer-health products, and nuclear and precision-health-solutions products to retail pharmacies, hospitals, physician offices, ambulatory care centers, and other healthcare providers across the United States; Cardinal Health is also one of the three major US pharmaceutical wholesalers alongside McKesson and Cencora) and Global Medical Products and Distribution (the at-Home Solutions home-healthcare-products distribution business, the Medical Products Manufacturing surgical and procedural-products manufacturing business including the Kendall and Cordis cardiovascular-and-endovascular medical-device franchise, and the Global Medical Products Distribution business including surgical-and-procedural-products distribution to hospitals and surgery centers). Pharmaceutical-and-medical-products distribution, specialty-pharmaceuticals distribution, surgical-and-procedural-products distribution and manufacturing, and home-healthcare-products distribution are unambiguously permissible at the activity level under standard Sharia methodology — these are general-purpose healthcare-services and medical-supply-chain activities. The financial screen passes with manageable leverage: Cardinal Health operates an investment-grade balance sheet with moderate leverage typical of a low-margin distribution business; the debt-to-market-cap ratio should be verified against the 33% Sharia threshold at the time of investment. Most major Sharia advisory boards classify Cardinal Health as permissible with purification of small interest-income components.
⚠️ Concerns
- •Minor interest income on cash and short-term investment balances — purification of a small portion of dividends may be advisable
- •Customer base includes retail pharmacies, hospitals, physician offices, ambulatory care centers, and other healthcare providers — these are operationally permissible at the activity level
- •Debt-to-market-cap ratio should be verified against the 33% Sharia threshold at the time of investment — Cardinal Health operates with moderate leverage typical of a low-margin distribution business and the ratio can move with market-cap volatility
- •Some downstream pharmaceutical-and-medical-products customers handle a small share of impermissible-end-use products (alcohol-containing pharmaceuticals or pork-derived gelatin capsules) — under standard Sharia screening methodology, the relevant industry classification is general-purpose healthcare-services distribution rather than the look-through end-use product mix
- •Historic opioid-distribution litigation has been settled with the National Opioid Settlement framework — verify the current ongoing-litigation-and-indemnification status at the time of investment
- •Generic-pharmaceutical pricing and reimbursement pressure can affect Pharmaceutical-segment margin — this is a business-cycle consideration rather than a Sharia screen concern
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →